Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase I Single-Center Open-label Study of C.001 in Patients With Significant Retinal Pigment Epithelium Mediated Maculopathy (RMM)

This is a first-in-human Phase 1 study evaluating the safety and tolerability of C.001 in patients with retinal diseases involving degeneration of the retinal …

Geographic AtrophyStargardt DiseaseRPE-mediated Maculopathy+1 more

Estimated

~$10 – $8,750

Cellio Therapeutics IncNCT07594236